Long Focus Capital Management, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
Long Focus Capital Management, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$251,000
-64.1%
10,000
-56.5%
0.02%
-67.1%
Q2 2022$699,000
-7.2%
23,0000.0%0.07%
-24.7%
Q1 2022$753,000
-40.5%
23,000
-52.1%
0.10%
-42.3%
Q4 2021$1,266,00048,0000.17%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$76,391,00014.09%
Opaleye Management Inc. 330,000$8,702,0001.85%
Highlander Partners, L.P. 27,600$728,0000.89%
Ikarian Capital, LLC 200,000$5,274,0000.79%
Integral Health Asset Management, LLC 103,000$2,716,0000.75%
KRS Capital Management, LLC 32,841$866,0000.74%
Ghost Tree Capital, LLC 55,000$1,450,0000.52%
MADDEN SECURITIES Corp 39,312$1,037,0000.49%
LBJ Family Wealth Advisors, Ltd. 30,359$801,0000.47%
Ikarian Capital, LLC 100,000$2,637,0000.39%
View complete list of REATA PHARMACEUTICALS INC shareholders